About three months ago, IGM Biosciences announced plans to stay afloat by focusing its resources on a clinical-stage autoimmune asset.
Catalyst Pharmaceuticals’ controversial $375,000 rare autoimmune disease drug now won’t face generic competition from Teva until Feb. 25, 2035, thanks to a ...
The best all-in-one computer will give you a full desktop PC experience in a sleek, streamlined package, making them some of the most popular computers on the market. Leading the list is the Apple ...
Mune agentic chimiro chekutarisa chinokura kupfuura kupindirana kweUI kunosanganisira kumashure-yekupedzisira otomatiki kuita sarudzo pachinzvimbo ichivimba chete neUI otomatiki simbiso inoshanduka ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果